Biomarker Testing Coverage Implemented Effective July 1, 2026
Effective January 1, 2027, 15 specific diabetes supply HCPCS codes will transition from medical/DME billing to exclusive pharmacy billing on Mississippi Medicaid. A transition period runs October 1–December 31, 2026, during which the billing team must update systems to route these codes to pharmacy claims and ensure providers switch members to preferred products on the Diabetic Supply List (DSL). Eight HCPCS codes for insulin pump supplies and adjunctive CGM remain eligible for medical/DME billing and are unaffected.